Understanding the molecular biology of brain tumors is key to prognosis and treatment said Le Bonheur Neuroscience Institute Co-Director Frederick Boop, MD, in his presentation How Molecular Biology Impacts Clinical Practice at the International Society for Pediatric Neurosurgery (ISPN) 2020 Virtual Meeting.